{"symbol":"LLY","provider":"yahoo-finance","fetchedAt":"2025-12-25T09:27:30.881Z","asOfDate":"2025-12-25","articles":[{"id":"275dceb5-bed9-33b6-b0c8-8ed3f7c655a6","title":"Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies","url":"https://finance.yahoo.com/news/caliways-fat-reduction-drug-candidate-020500815.html","publisher":"PR Newswire","publishedAt":"2025-12-25T02:05:00.000Z","relatedTickers":[],"mainIdea":"Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies","summary":"PR Newswire: Caliway's Fat Reduction Drug Candidate CBL-514 Completes U.S. FDA IND Submission for Phase 2 Clinical Study in Weight Management, Expanding Development Combined with GLP-1RA-Based Weight-Loss Therapies. Caliway Biopharmaceuticals (TWSE: 6919) today announced that it has completed the submission of an Investigational New Drug (IND) application to the U.S. FDA for a Phase 2 clinical study of its world's first large-area localized fat reduction drug candidate, CBL-514, for the weight management indication. This submission accelerates the clinical development of CBL-514 in combination with GLP-1R agonist (GLP-1RA) therapies and expands the Company's R&D footprint in the global weight management fie"},{"id":"d646d17f-65d4-3c5b-943a-6814d905b8c6","title":"Weight-loss pill approval spurs food industry overhaul","url":"https://finance.yahoo.com/video/weight-loss-pill-approval-spurs-224626785.html","publisher":"Reuters Videos","publishedAt":"2025-12-24T22:46:26.000Z","relatedTickers":["CAG","NSRGF","NVO"],"mainIdea":"Weight-loss pill approval spurs food industry overhaul","summary":"Reuters Videos: Weight-loss pill approval spurs food industry overhaul. Related tickers mentioned: CAG, NSRGF, NVO."},{"id":"727ca8e3-ac25-33d3-8de8-b180eb99424d","title":"Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever","url":"https://finance.yahoo.com/m/727ca8e3-ac25-33d3-8de8-b180eb99424d/got-%241%2C000%3F-2-high-yield.html","publisher":"Motley Fool","publishedAt":"2025-12-24T22:46:00.000Z","relatedTickers":["BMY","MDT","PFE"],"mainIdea":"Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever","summary":"Motley Fool: Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever. If you are looking for high yields, this drug maker and this device maker are both worth a deep dive today. Related tickers mentioned: BMY, MDT, PFE."}]}
